How $400,000 in JEPQ Pushed a Retiree’s Medicare Premium Up $1,000 a Year
A retiree collecting monthly distributions from a popular Nasdaq income ETF watched a Medicare surcharge quietly appear on their premium bill, and the fund's fact sheet never warned them it was coming.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
A retiree holding JPMorgan Nasdaq Equity Premium Income ETF (NASDAQ:JEPQ) with a $400,000 balance collected roughly $43,640 in distributions over the past 12 months. That income pushed modified adjusted gross income across a Medicare IRMAA line, and the surcharge quietly followed: an extra $95.70 a month, or about $1,148 a year, added to Part B and Part D premiums. The ETF didn’t advertise that number. It just showed up.
Cost You Can See on the Fact Sheet
JEPQ charges a 0.35% expense ratio. That’s $35 per $10,000 per year, or roughly $1,400 on a $400,000 position. Compounded over 20 years against a plain Nasdaq-100 index fund charging 0.15%, that fee gap alone can quietly siphon tens of thousands from a balance of this size.
At the current price of $59.79, $400,000 buys about 6,690 shares. Trailing 12-month distributions of $6.52319 per share produce roughly $43,640 in taxable income. The fund’s annualized forward rate of $8.45964 implies closer to $56,600 if recent payouts hold. Either figure lands a single filer above the $109,000 MAGI threshold that triggers the first IRMAA tier.
What the Factsheet Doesn’t Highlight
JEPQ’s yield is engineered from a covered-call overlay on Nasdaq-100 exposure. Premiums collected from those written calls flow through to shareholders largely as ordinary income rather than as qualified dividends. Every dollar hits MAGI at the retiree’s marginal rate and counts fully toward IRMAA brackets. Qualified dividends and long-term capital gains, by contrast, get preferential tax treatment and land in the same bucket for Medicare purposes but arrive on the investor’s schedule, not the fund’s.
IRMAA works as a cliff. Cross the $109,000 individual line by a single dollar, and you pay the full surcharge for 12 months. The lookback compounds the trap: 2026 premiums are set from 2024 tax returns, so this year’s distributions will set up the 2028 premium bill. Meanwhile, the options overlay caps upside. JEPQ has returned 20.13% over the past year and 10.08% year to date through August 25, 2026. In sharper rallies of the underlying index, written calls get exercised or repurchased at a loss, and JEPQ trails.
Cheaper Mirror for Nasdaq-100 Exposure
Investors seeking the same underlying exposure without the ordinary-income surcharge can hold a straight Nasdaq-100 fund: Invesco QQQ Trust (NASDAQ:QQQ) at a 0.20% expense ratio, or Invesco NASDAQ 100 ETF (NASDAQ:QQQM) at 0.15%. Neither pays a fat monthly distribution, and that’s the tradeoff. But an investor who needs cash can sell shares on their own timetable, harvesting long-term capital gains at preferential rates and controlling exactly when income hits MAGI. For a retiree threading an IRMAA cliff, that timing control is the point.
A 2027 Social Security COLA tracking near 3.1% won’t cover an IRMAA surcharge triggered by ETF distributions the beneficiary didn’t consciously spend. The surcharge is only one of several premium traps tied to income from two years ago, which we mapped in a free Medicare guide.
What This Means for You
Pull last year’s 1099-DIV from JEPQ. Compare Box 1a (total ordinary dividends) to Box 1b (qualified dividends). If the gap is wide, ask the question the fund’s marketing never puts on page one: is the monthly deposit worth the Medicare bracket it’s parking you in, and would a lower-cost Nasdaq-100 fund plus disciplined selling deliver the same cash flow with less MAGI drag?
Contact [email protected] for any questions or corrections.








